Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
At close: Dec 9, 4:00 PM EST
$3.90
0.030.78%
After Hours: 9:25 AM EST
Comments
Loading...
CytomX Therapeutics (CTMX) Stock Price, Quote, News & History
CTMXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy CytomX Therapeutics (CTMX) stock?
You can purchase shares of CytomX Therapeutics (NASDAQ:CTMX) through any online brokerage.
Who are CytomX Therapeutics (CTMX) competitors?
Other companies in CytomX Therapeutics’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Altimmune Inc (NASDAQ:ALT), Prothena Corp PLC (NASDAQ:PRTA) and MapLight Therapeutics Inc (NASDAQ:MPLT).
What is the forecast, or price target, for CytomX Therapeutics (CTMX) stock?
CytomX Therapeutics has a consensus price target of $6.06.
What is the current price for CytomX Therapeutics (CTMX)?
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $3.915 last updated December 9, 2025 at 3:54 PM EST.
Does CytomX Therapeutics (CTMX) pay a dividend?
There are no upcoming dividends for CytomX Therapeutics.
When is CytomX Therapeutics (NASDAQ:CTMX) reporting earnings?
CytomX Therapeutics does not have any upcoming earnings scheduled.
Is CytomX Therapeutics (CTMX) going to split?
There is no upcoming split for CytomX Therapeutics.
What sector and industry does CytomX Therapeutics (CTMX) operate in?
CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
